Oral ulcerative colitis drug Zeposia is actively prescribed
By Eo, Yun-Ho | translator Kim, Jung-Ju
24.02.03 05:50:20
가나다라
0
Lands in major hospitals nationwide, including SMC, SNUH, AMC
Has been reimbursed since January...Convenience in intake as an oral drug works as an advantage
According to industry sources, BMS Korea’s ‘Zeposia Cap (ozanimod)’ has passed drug committee (DC) reviews of major tertiary hospitals in Korea including Samsung Medical Center, Seoul National University Hospital, Seoul Asan Medical Center, as well as medical institutions including Yeungnam University Hospital, Wonkwang University Hospital, Wonju Severance Hospital, Chonnam National University Hospital, Chosun University Hospital, and Hanyang University Guri Hospital.
The drug has been expanding its prescription area after receiving insurance reimbursement in January thi
Eo, Yun-Ho(unkindfish@dailypharm.com)
If you want to see the full article, please JOIN US (click)